IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
2.100
+0.010 (0.48%)
At close: Sep 12, 2025, 4:00 PM EDT
2.150
+0.050 (2.38%)
Pre-market: Sep 15, 2025, 9:23 AM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $9.53 million as of September 15, 2025. Its market cap has decreased by -60.59% in one year.
Market Cap
9.53M
Enterprise Value
-574.59K
1-Year Change
-60.59%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $9.53M, a decrease of -94.92%. That is a compound annual growth rate of -51.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 9.53M | -48.86% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |